1. Home
  2. EXPO vs CNS Comparison

EXPO vs CNS Comparison

Compare EXPO & CNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXPO
  • CNS
  • Stock Information
  • Founded
  • EXPO 1967
  • CNS 1986
  • Country
  • EXPO United States
  • CNS United States
  • Employees
  • EXPO N/A
  • CNS N/A
  • Industry
  • EXPO Professional Services
  • CNS Investment Managers
  • Sector
  • EXPO Consumer Discretionary
  • CNS Finance
  • Exchange
  • EXPO Nasdaq
  • CNS Nasdaq
  • Market Cap
  • EXPO 4.0B
  • CNS 4.2B
  • IPO Year
  • EXPO 1990
  • CNS 2004
  • Fundamental
  • Price
  • EXPO $74.11
  • CNS $75.50
  • Analyst Decision
  • EXPO Strong Buy
  • CNS Sell
  • Analyst Count
  • EXPO 1
  • CNS 4
  • Target Price
  • EXPO $120.00
  • CNS $77.50
  • AVG Volume (30 Days)
  • EXPO 321.1K
  • CNS 181.0K
  • Earning Date
  • EXPO 07-24-2025
  • CNS 07-16-2025
  • Dividend Yield
  • EXPO 1.61%
  • CNS 3.17%
  • EPS Growth
  • EXPO 3.59
  • CNS 18.98
  • EPS
  • EXPO 2.04
  • CNS 3.06
  • Revenue
  • EXPO $518,720,000.00
  • CNS $529,174,000.00
  • Revenue This Year
  • EXPO $4.23
  • CNS $5.81
  • Revenue Next Year
  • EXPO $7.20
  • CNS $12.38
  • P/E Ratio
  • EXPO $36.58
  • CNS $25.54
  • Revenue Growth
  • EXPO 2.58
  • CNS 8.82
  • 52 Week Low
  • EXPO $72.43
  • CNS $68.99
  • 52 Week High
  • EXPO $115.75
  • CNS $110.67
  • Technical
  • Relative Strength Index (RSI)
  • EXPO 42.63
  • CNS 55.51
  • Support Level
  • EXPO $72.43
  • CNS $75.60
  • Resistance Level
  • EXPO $75.84
  • CNS $78.03
  • Average True Range (ATR)
  • EXPO 1.61
  • CNS 1.61
  • MACD
  • EXPO -0.02
  • CNS 0.29
  • Stochastic Oscillator
  • EXPO 28.27
  • CNS 95.11

About EXPO Exponent Inc.

Exponent Inc is a science and engineering consulting firm that provides solutions to complex problems. The company's consultant team is composed of scientists, physicians, engineers, as well as business and regulatory consultants. The company currently operates through two segments. The engineering and other scientific segments, which account for the majority of revenue, provide servicing encompassing biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, etc. The environmental and health segment covers chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences and others. The company generates almost all of its revenues from America.

About CNS Cohen & Steers Inc

Cohen & Steers is a niche asset manager concentrating on real estate securities. The firm invests mainly in the equity shares of real estate investment trusts, with holdings in domestic and international real estate securities accounting for close to two thirds of its $79.3 billion in managed assets at the end of January 2024. Cohen & Steers also manages portfolios dedicated to preferred securities, utilities stocks, and other high-yield offerings. The firm's distribution is balanced among its closed-end funds, open-end funds, and institutional accounts. During the past four calendar quarters, the company garnered 42% (27%) of its managed assets (base management fees) from institutional clients, 45% (52%) from open-end funds, and 13% (21%) from closed-end funds.

Share on Social Networks: